Terms: = Brain cancer AND SRGAP3, MEGAP, 9901, ENSG00000196220, ARHGAP14, KIAA0411, WRP AND Treatment
3 results:
1. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Le Péchoux C; Laplanche A; Faivre-Finn C; Ciuleanu T; Wanders R; Lerouge D; Keus R; Hatton M; Videtic GM; Senan S; Wolfson A; Jones R; Arriagada R; Quoix E; Dunant A;
Ann Oncol; 2011 May; 22(5):1154-1163. PubMed ID: 21139020
[TBL] [Abstract] [Full Text] [Related]
2. Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme (GBM) 8401 cells.
Huang TY; Tsai TH; Hsu CW; Hsu YC
J Agric Food Chem; 2010 Oct; 58(19):10639-45. PubMed ID: 20822178
[TBL] [Abstract] [Full Text] [Related]
3. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract] [Full Text] [Related]
